Abstract
In humans, myogenic stem cell (SC) enumeration is an important measurement used to determine the SC response in vivo to various physiological stimuli. The current standard for enumeration is immunohistochemistry (IHC) with antibodies against common SC markers (i.e. Pax7, NCAM). Fluorescent activated cell sorting (FACS) analysis may provide a more accurate determination of changes in the SC pool and provide additional analysis unachievable with IHC. FACS analysis revealed Pax7+ cells/mg isolated from 50mg fresh tissue increased 36% 24h after injury. The number of Pax7+ cells/mg in G2/M phase of the cell cycle increased 202% after 24h and cells/mg in G1/G0 and S‐phase increased 32% and 59% respectively. IHC data illustrated, in relation to N‐CAM or C‐Met alone, Pax7 alone was expressed on a greater number of cells. Furthermore, all 3 markers appear to sufficiently and similarly report SC expansion after injury (26–36%). Here we illustrate the use of FACS as a precise method of enumerating SC number on a per milligram tissue basis, providing a more easily understandable relation to muscle mass as opposed to number of myonuclei or fiber number. Although IHC is a powerful tool for SC analysis, FACS is an objective, reliable and effective method for SC quantification and can provide additional information such as cell‐cycle kinetics more accurately than IHC alone.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
